Breaking News, Financial News

ICON 3Q

ICON revenues dropped, but earnings were strong.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

ICON 3Q09 3Q Revenues: $220 million (-2%) 3Q Earnings: $24 million (+12%) YTD Revenues: $660 million (+2%) YTD Earnings: $63 million (+11%) Comments: Chief executive officer Peter Gray remarked, “While higher than normal cancellations held back net business awards, the levels of business opportunity continue to be strong and we remain optimistic for the future.”...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters